Valuation: Virbac

Market Cap 287.78Cr 331.62Cr 269.47Cr 246.5Cr 465.35Cr 32TCr 471.43Cr 3.15TCr 1.24TCr 16TCr 1.25TCr 1.22TCr 53TCr P/E 2026 *
16.6x
P/E 2027 * 15x
Enterprise Value 300.45Cr 346.22Cr 281.34Cr 257.35Cr 485.85Cr 33TCr 492.19Cr 3.29TCr 1.29TCr 16TCr 1.3TCr 1.27TCr 55TCr EV / Sales 2026 *
1.94x
EV / Sales 2027 * 1.79x
Free-Float
49.03%
Yield 2026 *
0.51%
Yield 2027 * 0.6%
1 day+2.08%
1 week-0.59%
Current month-0.15%
1 month+4.33%
3 months-6.90%
6 months-2.32%
Current year-3.16%
1 week 331
Extreme 331
338.5
1 month 310.5
Extreme 310.5
344.5
Current year 310.5
Extreme 310.5
381
1 year 297
Extreme 297
381
3 years 243
Extreme 243
392
5 years 220.5
Extreme 220.5
440.5
10 years 102.48
Extreme 102.479
440.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
+2.08%-0.59% - - 327.43Cr
+2.64%+1.18%-47.49%-57.42% 3.12TCr
-8.09%-8.99%+72.62%+98.68% 1.31TCr
+2.84%+4.57%-12.84%+3.95% 385.47Cr
+1.48%+0.59%+4.89%+22.24% 327.43Cr
-0.83%+13.33%+49.09%+28.33% 213.65Cr
+2.35%+1.16%+10.79%+27.37% 190.23Cr
-0.64%-2.07%+34.75%+138.44% 146.07Cr
-0.33%+12.95%-16.44%-3.22% 121.8Cr
+0.31%+1.87%-14.73%-46.13% 99Cr
Average +0.20%+0.06%+8.96%+23.58% 656.88Cr
Weighted average by Cap. +0.03%-2.35%-7.13%-2.45%

Financials

2026 *2027 *
Net sales 155.09Cr 178.72Cr 145.23Cr 132.85Cr 250.79Cr 17TCr 254.07Cr 1.7TCr 666.77Cr 8.51TCr 671.02Cr 656.44Cr 28TCr 164.73Cr 189.83Cr 154.25Cr 141.1Cr 266.38Cr 18TCr 269.86Cr 1.8TCr 708.2Cr 9.03TCr 712.72Cr 697.23Cr 30TCr
Net income 17Cr 20Cr 16Cr 15Cr 28Cr 1.88TCr 28Cr 187.45Cr 74Cr 938.48Cr 74Cr 72Cr 3.12TCr 19Cr 22Cr 18Cr 16Cr 31Cr 2.08TCr 31Cr 207.64Cr 81Cr 1.04TCr 82Cr 80Cr 3.46TCr
Net Debt 13Cr 15Cr 12Cr 11Cr 20Cr 1.39TCr 21Cr 138.85Cr 54Cr 695.14Cr 55Cr 54Cr 2.31TCr 7.52Cr 8.66Cr 7.04Cr 6.44Cr 12Cr 825.02Cr 12Cr 82Cr 32Cr 412.21Cr 33Cr 32Cr 1.37TCr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change
06/26/06 337.50 +0.30%
05/26/05 €336.50 +0.75%
04/26/04 €334.00 -1.18%
03/26/03 €338.00 0.00%
31/26/31 €338.00 -0.44%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
338.50EUR
Average target price
411.88EUR
Spread / Average Target
+21.68%

Quarterly revenue - Rate of surprise